跳至主要内容
临床试验/IRCT138806142420N1
IRCT138806142420N1已完成3 期

Fertility outcome of hyperprolactinemic infertile women undergoing induction of ovulation for intrauterine insemination (IUI): A comparison between Bromocriptine and Cabergoline

Research deputy of Shiraz University of Medical Sciences0 个研究点目标入组 188 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
188

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 years 至 38 years(—)
性别
Female

入选标准

  • 1) Primary or secondary infertility, 2) Hyperprolactinemia with or without galactorrhea (prolactin>20ng/ml), 3) Normal HA except high prolactin level, normal HSG or laparoscopy and normal SA.
  • Exclusion criteria: 1) other causes of infertility such as tubal factor, male factor or unexplained infertility, 2) nausea, vomiting, orthostatic hypotension, chronic hypertension, headache, 3) sensitivity to ergot derivatives, 4) macroadenoma of pituitary gland, 5) previous use of bromocriptine or cabergoline

排除标准

  • 未提供

研究者

发起方
Research deputy of Shiraz University of Medical Sciences

相似试验